RDGL
SHORT CANDIDATEMeanRevComposite
27.70
Technical
12.20
Fundamental
32.90
Rank
—
Price
0.05
Hurst
0.23
As of
Oct 2, 2026
Daily
Vivos Inc.
HealthcareMedical DevicesVivos Inc. is a radiation oncology company developing yttrium-90-based medical devices for treating inoperable tumors. The company's lead product, RadioGel, is an injectable gel designed to deliver precision radionuclide therapy to cancerous tumors in humans and animals, while IsoPet targets solid tumors in animals. The company is also working on polymer platforms and laboratory equipment for drug delivery and thermal applications across several product lines.
Market cap
$22.1M
P/E (trailing)
—
P/E (forward)
—
PEG ratio
—
Dividend yield
0.00%
Beta
-0.55
52w range
0.04 – 0.12
Return on equity
-132.51%
Profit margin
0.00%
Revenue growth
+142.70%
Earnings growth
—
Price history
1Y: 0.04 (-41.8%) · range 0.04–0.09
Cycle position
20/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 62 · MODERATE · exit proximity 0
Conviction
35/ 100 · maturity 0%
Buildup.334
EMA entry setup.4262
Fundamentals.2533
Volume profile
POC
0.06
Price vs POC
-23.7%
Overhead supply
92%
Runway
+4.4%
Value area 0.04–0.07 · 92% of 120d volume overhead · heavy supply
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -11.22% | +0.34% | 3/20d |
| 40d | -11.22% | +0.34% | 3/40d |